Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0NC1Q
|
||||
Former ID |
DNCL002106
|
||||
Drug Name |
AMG 172
|
||||
Indication | Renal cancer [ICD9: 140-229, 189; ICD10:C64] | Phase 1 | [523744] | ||
Company |
Amgen
|
||||
Target and Pathway | |||||
Target(s) | CD70 | Target Info | Modulator | [550482] | |
KEGG Pathway | Cytokine-cytokine receptor interaction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.